GLP‑1s and Lymphedema: Surprising Research That Could Change Care

This episode opens with a research moment about GLP‑1 drugs (semaglutide/terzepatide) showing a dramatic reduction in breast cancer‑related lymphedema incidence and highlights how weight loss and lowered inflammation can help the lymphatic system. Guest Jana from Texas shares her lipoedema story — late diagnosis, vein treatments, major lipedema reduction surgeries on legs and arms (with brachioplasty), and the post‑op plan: supplements (mitochondrial support, enzymes, anti‑inflammatory formulas), compression strategies, Mobiderm, and deep tissue therapies to address fibrosis. The conversation covers practical self‑care: choosing low‑impact exercise like swimming, nutrition testing (MRT), GLP‑1 experiences for weight and inflammation, family implications, emotional responses to diagnosis, and the improved mobility and quality of life Jana is gaining after surgery.